Yahoo
Canadian Sec - Delayed Quote CAD

Diagnamed Holdings Corp. (DMED.CN)

0.0300 0.0000 (0.00%)
At close: October 30 at 1:54:21 PM EDT
Chart Range Bar
Loading chart for DMED.CN
  • Previous Close 0.0300
  • Open 0.0300
  • Bid 0.0300 x --
  • Ask 0.0350 x --
  • Day's Range 0.0300 - 0.0300
  • 52 Week Range 0.0300 - 0.2500
  • Volume 33,050
  • Avg. Volume 230,158
  • Market Cap (intraday) 3.948M
  • Beta (5Y Monthly) -1.05
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0300
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. The company focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It also engages in exploration of Colchester East Natural Hydrogen Project comprising of 2,104 claims located within the Cumberland Basin in Nova Scotia; and the Timiskaming District of northern Ontario. It has a collaboration agreement with EIREX for the development and commercialization of EIREX's novel modular carbon-free technology that extracts hydrogen from water. Diagnamed Holdings Corp. is headquartered in Toronto, Canada.

www.diagnamed.com

--

Full Time Employees

September 30

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

DMED.CN
53.85%
S&P/TSX Composite index (^GSPTSE)
11.78%

1-Year Return

DMED.CN
68.42%
S&P/TSX Composite index (^GSPTSE)
18.03%

3-Year Return

DMED.CN
25.00%
S&P/TSX Composite index (^GSPTSE)
88.90%

5-Year Return

DMED.CN
70.00%
S&P/TSX Composite index (^GSPTSE)
69.32%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -347.95%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -1.85M

  • Diluted EPS (ttm)

    -0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    293.76k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -464.46k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: